California Life Sciences Announces Five New Board Members

Back

San Francisco, CA – California Life Sciences (CLS), the state’s most impactful life sciences membership organization advocating for the sector and its diverse innovation pipeline, today announced five new board members who will each help support the association’s mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world.

“We have worked diligently to ensure CLS’s board and leadership represents a variety of experts in biotechnology, pharmaceuticals, and medical technology as well as academic institutions, the investment community, and other critical partners,” said CLS CEO and President Mike Guerra. “We’re excited to expand our board with leaders who will bring diverse expertise and insight to our work. I look forward to serving with each of them in the coming year.”

The new board members will begin their three-year terms with CLS effective August 15, 2024:

  1. Scott Bohn, Chief Development Officer & Head of Lab, Healthpeak
  2. Badia Boudaiffa, Vice President, North America Commercial Operations, Diabetes Care, Abbott
  3. Frederick Dorey, Special Counsel, Cooley Godward Kronish, LLP
  4. Jeff Farrow, Chief Financial Officer & Chief Strategy Officer, Tarsus
  5. Nicole Anderson Leonard, JD, MBA, Vice President & Executive Vice Dean, Academic Affairs, Cedars-Sinai Medical Center

About California Life Sciences: California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world. #WeAreCaliforniaLifeSciences